Skip to main content
YUNGJIN PHARM. CO., LTD logo

YUNGJIN PHARM. CO., LTD — Investor Relations & Filings

Ticker · 003520 ISIN · KR7003520004 KO Manufacturing
Open in API
Filings indexed 193 across all filing types
Latest filing 2021-11-29 Major Shareholding Noti…
Country KR South Korea
Listing KO 003520

About YUNGJIN PHARM. CO., LTD

https://eng.yungjin.co.kr/

Yungjin Pharm. Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of pharmaceutical products for domestic and international markets. The company's portfolio includes a range of prescription drugs, with a focus on areas such as cephalosporin antibiotics and antipsychotic medications. Yungjin Pharm is actively involved in advancing its R&D pipeline, which includes collaborative research for treatments of rare conditions like mitochondrial diseases. Leveraging extensive drug production expertise and R&D capabilities, the company operates as a key affiliate within the KT&G Group's bio/pharmaceutical business.

Recent filings

Filing Released Lang Actions
대규모기업집단현황공시[분기별공시(개별회사용)]
Major Shareholding Notification Classification · 100% confidence The document is a 'Corporate Group Status Disclosure' (기업집단현황공시) filed by Youngjin Pharm, a subsidiary of the KT&G corporate group. It provides detailed information on shareholding, inter-company transactions, and financial status as required by Korean regulatory authorities for large corporate groups. Since it is a formal regulatory disclosure regarding corporate structure and group status that does not fit into specific categories like 10-K or Earnings Release, it is classified as a Regulatory Filing (RNS).
2021-11-29 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Yungjin Pharm. Co., Ltd. covering the period from January 1, 2021, to September 30, 2021. It contains detailed financial statements, business operations, management analysis, and governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-11-15 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Youngjin Pharm, detailing quarterly financial results (revenue, operating profit, net income) for 2021 Q3. It provides key financial highlights and is clearly an initial announcement of financial performance rather than a full annual or interim report. Therefore, it fits the definition of an Earnings Release (ER). Q3 2021
2021-11-04 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Major Shareholding Notification Classification · 100% confidence The document is a 'Corporate Group Status Disclosure' (기업집단현황공시) filed by Youngjin Pharm, a subsidiary of the KT&G corporate group. This type of filing is a mandatory regulatory disclosure in South Korea regarding group structure, shareholdings, and inter-company transactions. Since it does not fit into specific categories like 10-K, IR, or M&A, and is a formal regulatory submission, it is classified under the fallback category for regulatory filings.
2021-08-31 Korean
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Yungjin Pharm Co., Ltd. for the period ending June 30, 2021. It contains comprehensive financial statements, business operations, management discussion, and governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2021
2021-08-17 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Report' (영업(잠정)실적) for Youngjin Pharm, detailing quarterly financial performance (revenue, operating profit, net income) for 2021 Q2. It provides key financial highlights and is explicitly labeled as provisional data. This fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly financial results. Q2 2021
2021-07-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.